跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
the-111
首页
药物
the-111
the-111
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-FUNGAL POLYPEPTIDES
EP 4438733 A3
申请人: BIOTALYS NV
优先权: 2020
CN
EP
US
WO
8 件公开
MULTIDENTATE AZA LIGANDS ABLE TO COMPLEX METAL IONS AND THE USE THEREOF IN DIAGNOSTICS AND THERAPY
EP 1417183 B1
申请人: BRACCO IMAGING SPA
优先权: 2001
CN
EP
US
6 件公开
Proteolysis resistant active VEGF
US 7491696 B2
申请人: BAYER INNOVATION GMBH
优先权: 2002
EP
US
6 件公开
Particulate materials and compositions for radio therapy
US 7959900 B2
申请人: XL SCI TECH INC
优先权: 2005
CN
US
6 件公开
FACTOR VIII SEQUENCES
US 2015158930 A1
申请人: UCL BUSINESS PLC THE NETWORK BUILDING
优先权: 2012
US
6 件公开
Human recombinant beta-interferon with improved solubility
US 7052687 B2
申请人: FRAUNHOFER GES FORSCHUNG
优先权: 1997
US
5 件公开
DEVICE FOR SEPARATING AN ANALYTE FROM OTHER COMPONENTS IN AN ELECTROLYTIC SOLUTION
EP 4419898 A1
申请人: NYCTEA TECH AB
优先权: 2021
CN
EP
US
WO
4 件公开
WATER-SOLUBLE GOLD (III) COMPLEXES, METHODS OF PRODUCING WATER-SOLUBLE GOLD (III) COMPLEXES AND THEIR USE
EP 3649081 B1
申请人: SZCZEPANIAK STANISLAW
优先权: 2017
EP
US
WO
4 件公开
Antibodies directed against CD127
EP 2955196 A1
申请人: EFFIMUNE
优先权: 2014
EP
US
4 件公开
RADIONUCLIDE AND NEAR-INFRARED DYE CONJUGATED ANTIBODY FOR DETECTION OF GD2-POSITIVE CANCER
EP 4612189 A1
申请人: UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION
优先权: 2022
EP
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈